By proceeding, you agree to our Terms of Use and Privacy Policy.
Rick Austin is currently Vice President Research at Harpoon Therapeutics
Talks About #biology
Preferred Locations #NorthAmerica
With TCEs being studied in both hematological and solid tumors (39 and 34 trials respectively), there are now more than one hundred projects in the preclinical stage.